Ledger.Open graph →
SEC Form D · Amendment · filed November 14, 2016

Adjuvance Technologies Inc

Offering
$7.0M
Sold
$2.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Gregory Poland · Rochester, MNDirectorJohn Gallo · New York, NYDirectorPhil Livingston · New York, NYDirectorChristopher Frigon · New York, NYExecTyler Martin · Roca, NEExec · DirectorJeffrey Gardner · New York, NYExecMary Gin · Pelham, NYDirectorGregg A. Jacobson · Houston, TXExecGeorge H. Capps, Ii · St. Louis, MODirectorRobert W. Karr · St. Louis, MOExecCharles A. Bolten · St. Louis, MOExec · DirectorMichael W. Yeadon · St. Louis, MOExec · DirectorDavid W. Griggs · St. Louis, MOExec · DirectorThomas P. Cirrito · St. Louis, MODirectorRajesh J. Devraj · St. Louis, MOExecAlbert Hummel · Aliso Viejo, CADirectorTodd Gillespie · Aliso Viejo, CADirectorTony Mingo · Aliso Viejo, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗